+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Trends in FDA Compliance and Enforcement for Regulated Computer Systems - Webinar (Recorded)

  • Webinar

  • 90 Minutes
  • March 2019
  • World Compliance Seminar
  • ID: 4755616
FDA requires that all computer systems used to produce, manage and report on “GxP” (GMP, GLC, GCP) related products be validated and maintained in accordance with specific rules. This webinar will help you understand the FDA’s current thinking on computer systems that are validated and subject to inspection and audit. As a “GxP” system, following Good Manufacturing, Laboratory and Clinical Practices, the computer system must be validated in accordance with FDA requirements. If electronic records and/or electronic signatures (ER/ES) are incorporated into the system, FDA’s CFR Part 11 guidance on ER/ES must be followed. This webinar will focus on the key areas that are most important, including security and data integrity. Implementing and following the System Development Life Cycle (SDLC) methodology is the best approach for computer system validation and maintaining data integrity. The life cycle approach takes all aspects of validation into account throughout the life of the system and the data that it houses. The data is a key asset for any FDA-regulated company and must be protected through its entire retention period.

Agenda

  • Learn about Computer System Validation (CSV) and the System Development Life Cycle (SDLC) Methodology
  • Understand “GxP” Systems
  • Understand 21 CFR Part 11, Electronic Records/Electronic Signatures (ER/ES)
  • Learn how Data Archival plays a key role in ensuring security, integrity and compliance
  • Learn how to develop a solid Validation Strategy that will take into account the system risk assessment and system categorization (GAMP V) processes
  • Learn about recent FDA findings for companies in regulated industries
  • Learn about recent trends in technology that need to be addressed in the CSV approach
  • Q&A

Who Should Attend

  • Pharmaceutical
  • Medical Device
  • Biotechnology
  • Tobacco and Related (Vapor, e-Cigarette, Cigar etc. )
  • Any other FDA-regulated industry
  • plus any Life Science Consulting or Contracting firm
  • Information technology managers and analysts
  • QC/QA managers and analysts
  • Clinical data managers and scientists
  • Compliance managers
  • Lab managers and staff
  • Automation analysts
  • Computer system validation specialists
  • GMP training specialists
  • Business stakeholders and individuals who are responsible for computer system validation planning
  • execution
  • reporting
  • compliance
  • and audit   
  • Consultants working in the life sciences
  • tobacco and related industries who are involved in computer system implementation
  • validation and compliance
  • Anyone involved in the planning
  • execution
  • and reporting of a clinical trial (sponsor, director, researcher, regulatory role, etc. )